What is it that makes a church building “sacred?” Why do we enter great churches and cathedrals and gasp with wonder while ...

Two masterpieces, centuries apart, reflect a theological insight centuries old: Mary was given not only to John, but to the ...

China Renaissance, which has funded many leading Chinese technology firms, made another winning bet after shares of stablecoin issuer Circle Internet Group more than doubled on their debut in New ...

State officials denied a permit for an elephant show at the Colorado Renaissance Festival, according to an animal advocacy group that threatened to sue the state over the issue. Attorneys with the ...

June 13 the library will host ‘How to RedFest’, where guests can learn how to prepare for a visit to a Renaissance Festival. The event is schedule for 7pm in Marvin Auditorium. The library ...

"I think of him like a modern-day Renaissance man, I mean, I'd always find out a little bit more about his background sometimes and then like how many lives have you led," said Dutle. Dutle said ...

Ever stopped by a Seattle bar or casual food spot and noticed a pinball machine or two? The region is a center for pinball enthusiasts, in part thanks to its culture of barcades and general ...

Leon County Schools may sue Renaissance Charter School to reclaim furniture and equipment purchased with taxpayer money. The school board recognized and celebrated graduating seniors, including ...

For manufacturing to continue growing our economy, creating jobs and developing the best products in the world, the United States must update its permitting laws and procedures. Permitting delays ...

Lawmakers aren't expected to approve Albritton's "rural renaissance" plan, which seeks to bolster health care, education, transportation and economic development in rural areas, or Perez's push to ...

Trump’s executive orders aim for a US nuclear energy renaissance, but without funding, support, and safety measures, the strategy may fall short. Last month, the White House issued four ...

A year after GSK pulled its BCMA-targeting antibody-drug conjugate (ADC) Blenrep from the US market as a later-line therapy for multiple myeloma, there are signs that the drug may still have a ...